Carlo Pastore*

Oncologist, Head of Oncology Department, Sanatrix Clinic, Rome, Italy

*Corresponding Author: Carlo Pastore, Oncologist, Head of Oncology Department, Sanatrix Clinic, Rome, Italy.

Received: November 02, 2023; Published: November 08, 2023

Abstract

This article describes the clinical case of a 60-year-old Patient who is currently in complete remission of metastatic pancreatic adenocarcinoma of the pancreas almost ten years after diagnosis. The Patient had a disease recurrence at the end of post-surgical adjuvant chemotherapy and was subsequently treated with a combination of chemotherapy, phytotherapy, hyperthermia. To date, he performs periodic radiological diagnostic checks that attest to the absence of macroscopically evident disease.

 Keywords: Pancreatic Adenocarcinoma; Chemotherapy; Radiotherapy; Phytotherapy

References

1. Cai J., et al. “Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis”. Cancer Letter 520 (2021): 1-11.
2. Springfeld C., et al. “Chemotherapy for pancreatic cancer”. Presse Medicine 48 (2019): e159-e174.
3. Neoptolemos JP., et al. “Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial”. Lancet10073 (2017): 1011-1024.
4. Kobayashi S., et al. “FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study”. BMC Cancer1 (2023): 177.
5. Massimo Bonucci., et al. “Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases”. Integrative Cancer Therapies3 (2018): 994-999. 
6. Herold Z., et al. “Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system”. World Journal of Gastrointestinal Oncology 9 (2021): 1109-1120.
7. Petenyi FG., et al. “Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study”. Diseases4 (2021): 81.
8. Carlo Pastore., et al. “A Phase-2 Study of High-dose Melatonin in Association with Active Hexose-correlated Compound (NK-Life) in Advanced Cancer Patients with Persistent Lymphocytopenia". Acta Scientific Medical Sciences10 (2022): 51-53.
9. Carlo Pastore. “Treatment of Platelet Deficiency in a Cohort of Patients by a Combination of Melatonin and 5-Methoxytryptamine". Acta ScientificMedical Sciences7 (2021): 66-67.
10. Kim A., et al. “Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery”. Nutrients11 (2021): 3801.
11. Burkoň P., et al. “Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration”. Biomedicines10 (2022): 2480.
12. Myrehaug S., et al. “Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions”. Expert Review of Anticancer Therapy 5 (2016): 523-530.
13. Carlo Pastore and Valeria Giannini. “Oncological Hyperthermia and Quality of Life". Acta Scientific Medical Sciences12 (2022): 29-32.

Citation

Citation: Carlo Pastore. “Complete Remission in Stage IV Pancreatic Cancer: A Case of Exceptional Response”.Acta Scientific Medical Sciences 7.12 (2023): 03-06.

Copyright

Copyright: © 2023 Carlo Pastore. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.